Senti Biosciences Inc (SNTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 0 | 0 | 0 | 338 | 937 |
| Gross Profit | N/A | N/A | N/A | 338 | 937 |
| Operating Expenses | 13,356 | 16,301 | 18,699 | 44,214 | 16,125 |
| Operating Income | -13,356 | -16,301 | -18,699 | -43,876 | -15,188 |
| Other Income | 2,153 | 4,190 | 10 | 7,261 | 938 |
| Pre-tax Income | -11,203 | -12,111 | -18,689 | -36,615 | -14,250 |
| Net Income Continuous | -11,203 | -12,111 | -18,689 | -36,615 | -14,250 |
| Net Income Discontinuous | N/A | N/A | -27 | 21,692 | -4,447 |
| Net Income | $-11,203 | $-12,111 | $-18,716 | $-14,923 | $-18,697 |
| EPS Basic Total Ops | -2.45 | -2.65 | -4.23 | -3.36 | -4.22 |
| EPS Basic Continuous Ops | -2.45 | -2.65 | -4.24 | -8.24 | -3.22 |
| EPS Basic Discontinuous Ops | N/A | N/A | 0.01 | 4.88 | -1.00 |
| EPS Diluted Total Ops | -2.45 | -2.65 | -4.23 | -3.36 | -4.22 |
| EPS Diluted Continuous Ops | -2.45 | -2.65 | -4.24 | -8.24 | -3.22 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 0.01 | 4.88 | -1.00 |
| EPS Diluted Before Non-Recurring Items | -2.45 | -2.60 | -4.20 | N/A | N/A |
| EBITDA(a) | $-12,862 | $-14,840 | $-17,225 | $-42,061 | $-13,977 |